Brianna Lau, Yufan F Wu, Sunan Cui, Jie Fu, Scott Jackson, Daniel Pham, Piotr Dubrowski, Shaila Eswarappa, Lawrie Skinner, Hiroki Shirato, Hiroshi Taguchi, Michael F Gensheimer, Harriet Gee, Alexander L Chin, Maximilian Diehn, Billy W Loo, Vitali Moiseenko, Lucas K Vitzthum
BACKGROUND AND PURPOSE: Concerns over chest wall toxicity has led to debates on treating tumors adjacent to the chest wall with single-fraction stereotactic ablative radiotherapy (SABR). We performed a secondary analysis of patients treated on the prospective iSABR trial to determine the incidence and grade of chest wall pain and modeled dose-response to guide radiation planning and estimate risk. MATERIALS AND METHODS: This analysis included 99 tumors in 92 patients that were treated with 25 Gy in one fraction on the iSABR trial which individualized dose by tumor size and location...
April 26, 2024: Radiotherapy and Oncology